These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25559655)

  • 21. Cholestatic liver injury after glimepiride therapy.
    Chounta A; Zouridakis S; Ellinas C; Tsiodras S; Zoumpouli C; Kopanakis S; Giamarellou H
    J Hepatol; 2005 Jun; 42(6):944-6. PubMed ID: 15885370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute cholestatic hepatitis induced by glimepiride].
    Sitruk V; Mohib S; Grando-Lemaire V; Ziol M; Trinchet JC
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1233-4. PubMed ID: 11173739
    [No Abstract]   [Full Text] [Related]  

  • 23. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
    Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfonylurea treatment in type 2 diabetes.
    Bester K; Ton J; Korownyk C
    Can Fam Physician; 2018 Apr; 64(4):295. PubMed ID: 29650607
    [No Abstract]   [Full Text] [Related]  

  • 25. [Safety is the issue again].
    Overbeck P
    MMW Fortschr Med; 2013 Oct; 155(17):26. PubMed ID: 24340377
    [No Abstract]   [Full Text] [Related]  

  • 26. [Glimepiride-induced cute cholestatic hepatitis].
    Heurgué A; Bernard-Chabert B; Higuero T; Lukas-Croisier C; Caron J; Cadiot G; Thiéfin G
    Ann Endocrinol (Paris); 2004 Apr; 65(2):174-5. PubMed ID: 15247878
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
    Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
    Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE; Hoehns JD
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract]   [Full Text] [Related]  

  • 29. Update on oral hypoglycemics (continuing education credit).
    White JR
    J Pract Nurs; 1994 Mar; 44(1):24-31; quiz 31-3. PubMed ID: 8158562
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical profile of the novel sulphonylurea glimepiride.
    Rosskamp R; Wernicke-Panten K; Draeger E
    Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S33-42. PubMed ID: 8864639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
    Scheen AJ
    Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination.
    Shaik NA; Shaik JP; Ali S; Imran A; Rao DK
    Food Chem Toxicol; 2010 Dec; 48(12):3432-5. PubMed ID: 20868721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summaries for patients. How do older diabetes drugs compare in their effects on heart and blood vessel disease?
    Ann Intern Med; 2012 Nov; 157(9):I-28. PubMed ID: 23128878
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hardly any hypoglycemias, constant weight--and still cost effective].
    MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute glimepiride-induced pancreatitis].
    Duboeuf T; De Widerspach-Thor A; Scotto B; Bacq Y
    Gastroenterol Clin Biol; 2004 Apr; 28(4):409-10. PubMed ID: 15146162
    [No Abstract]   [Full Text] [Related]  

  • 38. Mucosal lichenoid drug reaction associated with glimepiride: a case report.
    Hammami S; Ksouda K; Affes H; Sahnoun Z; Zeghal K
    Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2301-2. PubMed ID: 26166659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance determines efficacy of glimepiride in Type 2 diabetic patients not well controlled by diet alone.
    Shimizu H; Monden T; Nagai T; Shoda Y; Sato T; Yamada M; Mori M
    Diabet Med; 2005 Feb; 22(2):225-6. PubMed ID: 15660744
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
    Hermansen K; Kolotkin RL; Hammer M; Zdravkovic M; Matthews D
    Prim Care Diabetes; 2010 Jul; 4(2):113-7. PubMed ID: 20444662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.